Pt(IV) Prodrugs with NSAIDs as Axial Ligands
A chemo-anti-inflammatory strategy is of interest for the treatment of aggressive cancers. The platinum (IV) prodrug with non-steroidal anti-inflammatory drugs (NSAIDs) as axial ligands is designed to efficiently enter tumor cells due to high lipophilicity and release the cytotoxic metabolite and NS...
Main Authors: | Daniil Spector, Olga Krasnovskaya, Kirill Pavlov, Alexander Erofeev, Peter Gorelkin, Elena Beloglazkina, Alexander Majouga |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/8/3817 |
Similar Items
-
Prodrugs of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), More Than Meets the Eye: A Critical Review
by: Amjad M. Qandil
Published: (2012-12-01) -
Design, Synthesis and Hydrolytic Behavior of Mutual Prodrugs of NSAIDs with Gabapentin Using Glycol Spacers
by: Hiba Najeh Alsaad, et al.
Published: (2012-10-01) -
Synthesis, Characterization, and Antibacterial Activity of Novel Mutual Non-Steroidal Anti-inflammatory Prodrugs
by: Banaz mohammed hamadameen, et al.
Published: (2019-12-01) -
Dexibuprofen Therapeutic Advances: Prodrugs and Nanotechnological Formulations
by: Anna Gliszczyńska, et al.
Published: (2021-03-01) -
Computational Modeling, Docking, Synthesis, Characterization, and in vitro Cyclooxygenase Inhibitory Activity of Some Novel Non-Steroidal Anti-inflammatory Prodrugs
by: Dana Muhammad Hamad Ameen, et al.
Published: (2020-12-01)